Protamine Zinc Recombinant Human Insulin — FDA Animal & Veterinary Adverse Event (ADE) Reports
Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Protamine Zinc Recombinant Human Insulin is a active ingredient.
Total reports
Protamine Zinc Recombinant Human Insulin: 1869
Reports by species (top entries)
- Cat 850
- Dog 229
- Human 7
Top reported reactions (VEDDRA terms, top entries)
- Containers, Damaged 398
- INEFFECTIVE, GLYCEMIC CONTROL 390
- Lack of efficacy - NOS 336
- Vials, Damaged 239
- Hypoglycaemia 175
- Appearance, Abnormal 82
- Death by euthanasia 72
- Vomiting 70
- INEFFECTIVE, LOSS OF EFFECT 68
- Product Defect, General 67
Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b14.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).